Moderna | MRNA - Debt



Moderna reported $741M in Debt for its fiscal quarter ending in June of 2025.


Debt Change Date
Acadia Pharmaceuticals USD 56.29M 56.29M Jun/2025
Adcock Ingram Holdings ZAR 969.4M 688.86M Dec/2024
Agios Pharmaceuticals USD 48.76M 48.76M Jun/2025
Alnylam Pharmaceuticals USD 1.3B 271.5M Jun/2025
Amgen USD 56.2B 1.18B Jun/2025
Arrowhead Research USD 388.24M 21.18M Mar/2025
Biogen USD 6.59B 296.8M Jun/2025
BioMarin Pharmaceutical USD 603.87M 8.22M Jun/2025
Celltrion KRW 2.22T 24.87B Mar/2025
Cspc Pharmaceutical CNY 507.33M 118.46M Dec/2024
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Divis Laboratories Ltd 40M 40M Mar/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Incyte USD 42.41M 5.29M Jun/2025
Ionis Pharmaceuticals USD 1.42B 169.27M Jun/2025
Kangmei Pharma CNY 221.82M 958.68M Mar/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Malin Corporation EUR 0 0 Dec/2024
Moderna USD 741M 4M Jun/2025
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 1.44B 35.7M Jun/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Sarepta Therapeutics USD 1.35B 215.59M Jun/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Tilray USD 351.72M 15.26M Nov/2024
Ultragenyx Pharmaceutical USD 36.3M 1.98M Jun/2025
United Therapeutics USD 200M 100M Mar/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025
Zz Pientze Pharmaceu 1.12B 70.31M Mar/2025